Advancing Innovation in Cancer Care - Bringing the Next Wave of Oncology Products to Market

The rapid pace of innovation in oncology was displayed at the 2025 American Society of Clinical Oncology (ASCO) annual meeting, where research highlighted promising developments, including advances in immunotherapy and targeted therapies for rare cancers.

Scientific breakthroughs, including cell and gene therapies (CGT), personalized cancer vaccines, and targeted therapies, have helped to redefine approaches for certain cancers, contributing to the substantial progress achieved in five-year relative survival rates for many cancer types.

See how experts Tommy Bramley and Eric Monzon discuss the next wave of cancer care. To continue reading this article, please visit PharmExec.com.